BIIB vs WOLF · P/E 21, rev $9.89B vs rev $757.6M
Biogen Inc (BIIB) versus Wolfspeed Inc (WOLF) — a side-by-side from cached financials, not a winner call.
Biogen Inc (BIIB) is a drug manufacturers - general company listed on NASDAQ.
Wolfspeed Inc (WOLF) is a semiconductors company listed on US.
Latest reported BIIB revenue for 2025-12-31 was $9.89B. Net income was $1.29B. Revenue was up 2.2% from 2024-12-31 to 2025-12-31. BIIB currently screens at market cap $29.33B and trailing P/E 21.4.
Latest reported WOLF revenue for 2025-06-29 was $757.6M. Net income was -$1.61B. Revenue was down 6.1% from 2024-06-30 to 2025-06-29. WOLF currently screens at market cap $183.6M.
BIIB currently screens at market cap $29.33B and trailing P/E 21.4. WOLF currently screens at market cap $183.6M.
Not investment advice. Open the BIIB and WOLF stock pages for the full models.
Not investment advice.